Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
about
Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectivesChemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapyHyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal CarcinomatosisHyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyIntensive care unit admission after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Is it necessary?Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasmsExtensive cytoreductive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer.Primary appendiceal mucinous adenocarcinoma alongside with situs inversus totalis: a unique clinical case.Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy.Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?Pseudomyxoma peritonei as an intractable disease and its preoperative assessment to help improve prognosis after surgery: A review of the literature.Pseudomyxoma peritonei.Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 casesSystemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix.Hyperthermic Intraperitoneal Chemotherapy Following Cytoreductive Surgery Improves Outcome in Patients With Primary Appendiceal Mucinous Adenocarcinoma: A Pooled Analysis From Three Tertiary Care Centers.A comparative analysis of postoperative pancreatic fistulas after surgery with and without hyperthermic intraperitoneal chemoperfusion.A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the AppendixHigh-quality results of cytoreductive surgery and heated intraperitoneal chemotherapy perfusion for carcinomatosis at a low volume institution.Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment.A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers.Cytoreductive surgery and continuous hyperthermic peritoneal perfusion in patients with mesothelioma and peritoneal carcinomatosis: hemodynamic, metabolic, and anesthetic considerationsIncidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C.Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin.Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade.Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas.Clinicopathological analysis of primary epithelial appendiceal neoplasms.Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC.Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.Management of peritoneal carcinomatosis from colorectal cancer.Mucin as a therapeutic target in pseudomyxoma peritonei.Cure for peritoneal metastases? An evidence-based review.Intraperitoneal chemotherapy: rationale, applications, and limitations.Surgical treatment of peritoneal carcinomatosis: current treatment modalities.Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis.Appendiceal Mucinous Neoplasms: Diagnosis and Management.Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
P2860
Q26744031-8857EB9E-AC6B-4589-AB15-4B303F7A1C0EQ26768402-5516F6E2-EDE1-41A1-B5A0-D8FCA881AAF9Q28077394-B64D8E66-731F-4BEA-8503-2EC97A52E5B3Q33418610-75059C84-C32A-4579-85F7-D1ECA0C12FF0Q33569361-33A154BF-CF91-400D-BBFF-CD28A1CA7016Q33594164-D90EAFFC-6AE4-4D5B-A099-B7B797320CA0Q33909310-A026C62F-C125-49D6-8B54-A783DE6354F0Q33909347-90A73261-348D-4A2F-85AE-201B105900FAQ33940841-BC87EBED-3AC4-460D-9C8B-112EF1F853C8Q33951995-74B614B5-8DDE-4E70-A030-85B8C26A0F73Q34097998-A98266ED-1017-4DA7-8751-97ABD1160899Q34366940-3C826ED8-930B-4C7A-B5BB-7D6D44465E31Q34378008-41F57C72-0288-49A5-BDCF-393FAF6F9266Q34391046-674F0A26-CF80-499A-B77C-8C9CAD265771Q34391061-5F6D9B62-AE98-4B05-A29D-7D2586CBB617Q35137544-0C47DA02-5153-4DB6-9E87-8B193B7ABBACQ35902817-DE18261E-69B7-452D-BD8F-530756EE6C34Q35915699-AE8FBCB5-C8AB-4310-B12D-4D41C51D6998Q35955901-DFCF8B80-C4D9-42E8-94BE-9F6E52C852A3Q36048563-9966CE9A-0BEE-467C-9CFA-BAEA727496CBQ36306819-4D4E4765-30E2-4227-AF49-DFF8A24B918BQ36797297-4F7480E7-379D-4BA7-B36D-B5456311317EQ36989557-C56AB408-D835-49A0-AF9E-36608E4344DCQ37087589-9F851D69-D4E8-4113-A86A-D92611634267Q37264971-FCE14A3A-4BC2-421E-925E-F9A779C77DEEQ37267412-A507EDAF-68D9-47D4-AA69-8BF7E6BDF52BQ37375264-451F1514-C893-4E3B-BAC0-51616C207B83Q37404386-52539D31-3CB1-4E1F-ABE0-60FCF51589B4Q37442549-F07E28B6-8F78-462C-B16C-3F80701A01CDQ37512841-A560CC4B-673F-40FB-8073-754658A9ECB0Q37655525-1D653970-1976-4068-97A5-672891E1E019Q37662806-598703BF-AE54-4355-9427-0E93F5A476FFQ37910396-B2C93CCE-F3E2-42FF-B63D-13246BAFD5C3Q38010127-A149C35A-07D3-41D0-A4F4-AF57443719C2Q38117718-BCEF657C-DF82-4183-B8B2-B3FC5F10891FQ38156120-E95F69C3-A836-40BD-AD23-BA045AA9D327Q38163913-50ACD6BD-0CCC-487B-A568-25C15249B066Q38244051-26219107-1886-4289-8C97-E0FC29711CB6Q38701575-2B19BEDC-639D-403D-B4F6-832ACB6AAC0EQ40474762-A9BE59B5-9240-4DD1-A2E5-13B1D1EBEA05
P2860
Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Appendiceal neoplasms with per ...... eal hyperthermic chemotherapy.
@ast
Appendiceal neoplasms with per ...... eal hyperthermic chemotherapy.
@en
type
label
Appendiceal neoplasms with per ...... eal hyperthermic chemotherapy.
@ast
Appendiceal neoplasms with per ...... eal hyperthermic chemotherapy.
@en
prefLabel
Appendiceal neoplasms with per ...... eal hyperthermic chemotherapy.
@ast
Appendiceal neoplasms with per ...... eal hyperthermic chemotherapy.
@en
P2093
P1476
Appendiceal neoplasms with per ...... eal hyperthermic chemotherapy.
@en
P2093
Brian L Loggie
Edward A Levine
Gregory B Russell
John H Stewart
Jonathan C Hundley
Kim R Geisinger
Perry Shen
Robert F Bradley
P2860
P2888
P304
P356
10.1007/S10434-006-9708-2
P577
2006-03-14T00:00:00Z